Neonatal hypoxia ischaemia: mechanisms, models, and therapeutic challenges

LJ Millar, L Shi, A Hoerder-Suabedissen… - Frontiers in cellular …, 2017 - frontiersin.org
Neonatal hypoxia-ischaemia (HI) is the most common cause of death and disability in
human neonates, and is often associated with persistent motor, sensory, and cognitive …

Infection-induced inflammation and cerebral injury in preterm infants

T Strunk, T Inder, X Wang, D Burgner… - The Lancet infectious …, 2014 - thelancet.com
Preterm birth and infectious diseases are the most common causes of neonatal and early
childhood deaths worldwide. The rates of preterm birth have increased over recent decades …

Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response

M Brines, A Cerami - Journal of internal medicine, 2008 - Wiley Online Library
In its classic hormonal role, erythropoietin (EPO) is produced by the kidney and regulates
the number of erythrocytes within the circulation to provide adequate tissue oxygenation …

Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy

JE Orrock, K Panchapakesan, G Vezina, T Chang… - Pediatric …, 2016 - nature.com
Background: Cytokines have been proposed as mediators of neonatal brain injury via
neuroinflammatory pathways triggered by hypoxia-ischemia. Limited data are available on …

Erythropoietin for infants with hypoxic–ischemic encephalopathy

RJ McPherson, SE Juul - Current opinion in pediatrics, 2010 - journals.lww.com
Erythropoietin for infants with hypoxic–ischemic encephalopa... : Current Opinion in Pediatrics
Erythropoietin for infants with hypoxic–ischemic encephalopathy : Current Opinion in Pediatrics …

Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus

S Hamed, CL Bennett, C Demiot… - Wound Repair and …, 2014 - Wiley Online Library
Developing a new drug is expensive: the cost of going from bench to bedside is about $ US1
billion. Therefore, the repurposing of an approved drug is potentially rewarding because it …

Multiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications

VV Krishhan, IH Khan, PA Luciw - Critical reviews in biotechnology, 2009 - Taylor & Francis
Flow cytometry was originally established as an automated method for measuring optical or
fluorescence characteristics of cells or particles in suspension. With the enormous increase …

Splenic immune cells in experimental neonatal hypoxia–ischemia

N Fathali, RP Ostrowski, Y Hasegawa, T Lekic… - Translational stroke …, 2013 - Springer
Neuroimmune processes contribute to hypoxic–ischemic damage in the immature brain and
may play a role in the progression of particular variants of neonatal encephalopathy. The …

The effects of topical erythropoietin on non-surgical treatment of periodontitis: a preliminary study

H Aslroosta, S Yaghobee, S Akbari, N Kanounisabet - BMC Oral Health, 2021 - Springer
Background The purpose of periodontal treatments is to reduce inflammation, restore
gingival health and clinical attachment level gain by controlling microbial plaque formation …

[HTML][HTML] Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice

S Hamed, Y Ullmann, D Egozi, E Daod, E Hellou… - Journal of investigative …, 2011 - Elsevier
Diabetes mellitus disrupts all phases of the wound repair cascade and leads to development
of chronic wounds. We previously showed that topical erythropoietin (EPO) can promote …